Overview
This is a retrospective-prospective study conducted at Zhongshan Hospital, Fudan University, to explore portal vein thrombosis (PVT) in patients with cirrhosis and gastroesophageal varices (GEV). It aimed to provide insights into the diagnosis, follow-up, and factors influencing PVT recanalization, to help patients, families, and healthcare providers understand the disease and related clinical management.
Eligibility
Inclusion Criteria:
- diagnosed as cirrhosis and confirmed gastroesophageal varices by endoscopy;
- all patients were diagnosed as PVT by CTA at admission.
Exclusion Criteria:
- patients with hepatocellular carcinoma;
- patients with extrahepatic malignancies;
- history of liver transplantation or TIPS;
- lack of information regarding anticoagulation therapy;
- those with cavernous transformation of the portal vein(CTPV) .
- lack of information regarding anticoagulation therapy;
- history of liver transplantation or TIPS;
- patients with extrahepatic malignancies;


